Juan-Carlos Acosta

Medicine & Life Sciences

1. Cellular Senescence 100%
2. Oncogenes 49%
3. Neoplasms 29%
4. K562 Cells 24%
5. Leukemia 23%
6. Myeloid Leukemia 23%
7. Apoptosis 20%
8. Cell Differentiation 20%
9. Inflammasomes 20%
10. Cell Cycle 20%
11. Myeloid Cells 19%
12. Up-Regulation 18%
13. Cell Cycle Checkpoints 17%
14. Interleukin-8B Receptors 16%
15. Fibroblasts 16%
16. Autosomal Recessive Hypercholesterolemia 15%
17. MAP-kinase-activated kinase 2 14%
18. Genes 13%
19. condensin complexes 13%
20. Chemokines 13%
21. Carcinogenesis 13%
22. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13%
23. Genomic Instability 12%
24. Amifostine 12%
25. Isotope Labeling 12%
26. Histone Demethylases 12%
27. Proteins 11%
28. Nuclear Pore 11%
29. Severe Acute Respiratory Syndrome 10%
30. Toll-Like Receptor 2 10%
31. Ketones 10%
32. Erythroid Cells 10%
33. Coronavirus 10%
34. Regeneration 10%
35. Weapons 10%
36. Temozolomide 10%
37. Heterochromatin 10%
38. Ligands 10%
39. p53 Genes 10%
40. Cyclin-Dependent Kinase Inhibitor p27 9%
41. Protein Stability 9%
42. Genetic Heterogeneity 9%
43. Pluripotent Stem Cells 9%
44. T-Cell Lymphoma 9%
45. Cholangiocarcinoma 9%
46. Mitosis 9%
47. Growth 9%
48. GTP Phosphohydrolases 9%
49. Anthracyclines 9%
50. Imatinib Mesylate 9%